Nurofen Forte Orange (Ibuprofen)

Ibuprofen works by inhibiting the cyclo‑oxygenase enzymes COX‑1 and COX‑2, which are needed to convert arachidonic acid into prostaglandins. Lower prostaglandin levels decrease inflammation, blunt pain signals and reset the hypothalamic temperature set‑point, producing analgesic, anti‑inflammatory and antipyretic effects.

The appropriate dose of Nurofen Forte Orange is determined by the prescribing clinician based on the patient’s age, weight, condition and overall health status. Patients should follow the specific dosing instructions provided by their healthcare professional.

Ibuprofen is generally avoided in the third trimester of pregnancy because of potential fetal risks, and it should be used with caution earlier in pregnancy. During breastfeeding, small amounts pass into milk; clinicians usually recommend alternative analgesics unless benefits outweigh risks.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, and will request trade or institutional credentials before providing pricing, availability, shipping details and necessary import documentation.

Nurofen Forte Orange (ibuprofen) offers a balanced profile of analgesic, anti‑inflammatory and antipyretic activity, with a relatively short half‑life compared with longer‑acting NSAIDs like naproxen. Its safety and efficacy are well‑established, though individual response and tolerance may vary, making clinician selection important.

Store Nurofen Forte Orange at ambient temperature, ideally below 25 °C. Keep the tablets in their original packaging, protect them from moisture and direct sunlight, and ensure the container is tightly closed to maintain product stability.

Nurofen Forte Orange is taken orally, usually with water. It can be swallowed with or without food, although taking it with food or milk may reduce the likelihood of gastrointestinal discomfort.

Serious risks include gastrointestinal bleeding or ulceration, renal impairment, severe allergic reactions such as anaphylaxis, and increased cardiovascular events in high‑risk patients. Patients should be monitored for signs like black stools, swelling, difficulty breathing or sudden chest pain.

Ibuprofen should be avoided by individuals with active gastrointestinal ulcers, severe renal or hepatic impairment, known hypersensitivity to ibuprofen or other NSAIDs, and by women in the third trimester of pregnancy. It is also contraindicated in patients with aspirin‑exacerbated respiratory disease.